Promoting Engagement and COVID-19 Testing for Health

NAActive, not recruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

January 8, 2025

Study Completion Date

August 31, 2025

Conditions
COVID-19
Interventions
BEHAVIORAL

COVID-19 Test Reporting

Participants will use a simple text-based data reporting tool which they will be asked to use to report any COVID-19 testing during the 12-month long tudy.

BEHAVIORAL

Personalized Nudges via Text Messaging

Weekly behavioral nudges via mobile phone text messages, personalized to participants' diabetes status, race/ethnicity, age group, sex, and/or vaccine/testing history, will be sent in weeks 1-16 of the intervention to encourage adherence to COVID-19 testing and preventive behaviors as well as other behaviors important for diabetes management, prevention, or care.

BEHAVIORAL

Non-personalized Nudges via Text Messaging

Weekly behavioral nudges via mobile phone text messages will be sent in weeks 1-16 of the intervention sharing tips lifestyle behaviors important for diabetes management and prevention (e.g., exercise, eating a healthy diet, etc.).

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Morehouse School of Medicine

OTHER

collaborator

Georgia Institute of Technology

OTHER

lead

Emory University

OTHER

NCT06141850 - Promoting Engagement and COVID-19 Testing for Health | Biotech Hunter | Biotech Hunter